<DOC>
	<DOCNO>NCT00394901</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety pregabalin treatment postherpetic neuralgia dose-ranging manner .</brief_summary>
	<brief_title>A 13-Week , Randomized , Double-Blind , Multicenter , Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Visual Analogue Scale ( VAS ) pain high 40 mm . Pain sustain 3 month heal herpes zoster skin rash . Malignancy within past 2 year . Patients undergone neurolytic neurosurgical therapy postherpetic neuralgia . Creatinine clearance &lt; /= 30 mL/min ( estimate serum creatinine , body weight , age , sex use Cockcroft Gault equation , omit decimal fraction ) . Patients severe pain may impair self assessment pain due postherpetic neuralgia . Skin condition affect dermatome could alter sensation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>